Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000574426 | SCV000673212 | benign | Hereditary cancer-predisposing syndrome | 2022-12-08 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000645529 | SCV000767275 | likely benign | Multiple endocrine neoplasia type 4 | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000645529 | SCV004212428 | uncertain significance | Multiple endocrine neoplasia type 4 | 2022-07-30 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV003478281 | SCV004220749 | benign | not provided | 2023-07-12 | criteria provided, single submitter | clinical testing |